His primary scientific interests are in Breast cancer, Cancer, Internal medicine, Oncology and Genetics. The concepts of his Breast cancer study are interwoven with issues in Genome-wide association study, Genotype, Single-nucleotide polymorphism and Ovarian cancer. The Genotype study combines topics in areas such as Allele and Immunology.
Frans B. L. Hogervorst has included themes like Genetic predisposition and Bioinformatics in his Single-nucleotide polymorphism study. He has researched Cancer in several fields, including Cancer research, Gynecology and Endocrinology. His Oncology study integrates concerns from other disciplines, such as Colorectal cancer, Endometrial cancer and MSH6.
His primary areas of study are Breast cancer, Genetics, Internal medicine, Oncology and Cancer. His Breast cancer research incorporates elements of Cancer research and Single-nucleotide polymorphism, Genome-wide association study, Genotype. His research integrates issues of Haplotype, Gene mutation and Bioinformatics in his study of Single-nucleotide polymorphism.
Frans B. L. Hogervorst combines subjects such as Penetrance and Immunology with his study of Genotype. His Internal medicine research focuses on Pathology and how it relates to Comparative genomic hybridization. His work in Oncology covers topics such as Ovarian cancer which are related to areas like BRCA2 Protein.
His main research concerns Breast cancer, Internal medicine, Oncology, Genetics and Ovarian cancer. His biological study spans a wide range of topics, including CHEK2 and Single-nucleotide polymorphism, Genotype. His Oncology research includes themes of Germline mutation, Li–Fraumeni syndrome, Genetic predisposition, Case-control study and Gynecology.
His Germline mutation study combines topics in areas such as Genotyping and Genetic testing. His work on Locus, Allele, Genome-wide association study and Mutation as part of general Genetics research is frequently linked to Olaparib, thereby connecting diverse disciplines of science. His Ovarian cancer research includes elements of Complementation, Prostate, Proportional hazards model and Clinical significance.
His scientific interests lie mostly in Breast cancer, Oncology, Internal medicine, Genetics and Genotype. His research in Breast cancer intersects with topics in Case-control study and Cisplatin. His Oncology research integrates issues from Odds ratio, Pancreatic cancer, Estrogen receptor and Genetic predisposition.
The Genotype study combines topics in areas such as Ovarian cancer and Bioinformatics. His research on Genotyping also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
Sharon E. Plon;Diana M. Eccles;Douglas Easton;William D. Foulkes.
Human Mutation (2008)
Laminin receptor on platelets is the integrin VLA-6.
Arnoud Sonnenberg;Piet W. Modderman;Frans Hogervorst.
A common coding variant in CASP8 is associated with breast cancer risk
Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian.
Nature Genetics (2007)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
A. Petrij-Bosch;T. Peelen;M. Van Vliet;R. Van Eijk.
Nature Genetics (1997)
The α6β4 Integrin Is a Receptor for both Laminin and Kalinin
C.M. Niessen;F. Hogervorst;L.H. Jaspars;A.A. de Melker.
Experimental Cell Research (1994)
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary
C J van Asperen;R M Brohet;E J Meijers-Heijboer;N Hoogerbrugge.
Journal of Medical Genetics (2005)
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: